Omega Healthcare Investors, Inc. (OHI) Downgraded by Vetr Inc.

Omega Healthcare Investors, Inc. (NYSE:OHI) was downgraded by research analysts at Vetr from a “buy” rating to a “hold” rating in a report issued on Thursday, October 19th. They presently have a $33.33 price objective on the real estate investment trust’s stock. Vetr‘s price target suggests a potential upside of 4.98% from the stock’s previous close.

A number of other research firms also recently commented on OHI. Zacks Investment Research upgraded shares of Omega Healthcare Investors from a “sell” rating to a “buy” rating and set a $35.00 price target on the stock in a research report on Wednesday, October 4th. BidaskClub downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. ValuEngine raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $30.00 target price on shares of Omega Healthcare Investors in a research report on Tuesday, October 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. Omega Healthcare Investors currently has an average rating of “Hold” and an average price target of $33.07.

Shares of Omega Healthcare Investors (OHI) opened at 31.75 on Thursday. The stock’s 50 day moving average price is $31.98 and its 200-day moving average price is $32.41. Omega Healthcare Investors has a 52-week low of $28.11 and a 52-week high of $35.14. The firm has a market capitalization of $6.26 billion, a PE ratio of 16.75 and a beta of 0.53.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Wednesday, July 26th. The real estate investment trust reported $0.33 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.16). Omega Healthcare Investors had a return on equity of 8.88% and a net margin of 40.20%. The company had revenue of $194.00 million for the quarter, compared to the consensus estimate of $194.59 million. During the same quarter last year, the firm posted $0.87 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities research analysts anticipate that Omega Healthcare Investors will post $1.77 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Omega Healthcare Investors, Inc. (OHI) Downgraded by Vetr Inc.” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/28/omega-healthcare-investors-inc-ohi-lowered-to-hold-at-vetr-inc.html.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in Omega Healthcare Investors by 2.3% during the second quarter. Vanguard Group Inc. now owns 32,497,878 shares of the real estate investment trust’s stock valued at $1,073,080,000 after purchasing an additional 735,367 shares in the last quarter. BlackRock Inc. grew its position in Omega Healthcare Investors by 3.6% during the second quarter. BlackRock Inc. now owns 20,606,999 shares of the real estate investment trust’s stock valued at $680,443,000 after purchasing an additional 717,086 shares in the last quarter. State Street Corp grew its position in Omega Healthcare Investors by 4.3% during the second quarter. State Street Corp now owns 6,278,985 shares of the real estate investment trust’s stock valued at $207,335,000 after purchasing an additional 258,035 shares in the last quarter. Principal Financial Group Inc. grew its position in Omega Healthcare Investors by 137.5% during the second quarter. Principal Financial Group Inc. now owns 5,503,823 shares of the real estate investment trust’s stock valued at $181,736,000 after purchasing an additional 3,186,783 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Omega Healthcare Investors by 5.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,822,008 shares of the real estate investment trust’s stock valued at $93,098,000 after purchasing an additional 136,648 shares in the last quarter. 72.74% of the stock is currently owned by hedge funds and other institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply